Related Experiment Video
Updated: Jan 11, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Gastric remnant cancer: a comprehensive narrative review from carcinogenesis to treatment
José Darío Portillo-Miño1, Sandra Cifuentes2, Javier Morales3
1Grupo de Investigacion en Enfermedades Infecciosas y Cancer (GINFYCA), Centro de Investigaciones Clínicas, Fundacion Hospital San Pedro. Pasto, Nariño. Colombia; Grupo Colombiano de Investigacion en Helicobacter pylori, Bogotá, Colombia.
Abstract:
Gastric remnant cancer is cancer secondary to partial gastrectomy after five years. Peculiarities due to the gastrectomy status may influence this type of GC. Modifications in the gastric microbiome, luminal pH, dietary habits, increased bile reflux, and Epstein-Barr virus infection, together with the traditional GC risk factors, cooperate to increase the risk of cancer in the remnant stomach. H. pylori infection has been widely associated with GC, and its role in the pathogenesis of the remnant stomach, as well as the preventive effect of its eradication after gastrectomy, are issues of great scientific interest. Bariatric surgery is another condition potentially related to increased GC risk and challenges to its diagnosis. In this scenario, this article aims to review the current evidence of the fundamental aspects involved in developing the gastric remnant cancer.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Cancer Survival Analysis
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
